NextGen Biomed 2025, London, UK, March 12-14, 2025
Conference
Event
-
February 26, 2025
genOway's presentation on Thursday, March 13, 2025 | 4.30 p.m. GMT:
Assessment of translational tumor biology and efficacy in humanized mouse models
- Outlining genO-BRGSF-HIS mice: a CD34+-reconstituted model with functional human lymphoid and myeloid compartments without side effects
- Investigating human immune cell recruitment into tumor microenvironment in BRGSF-HIS mice
- Assessment of anti-tumoral compounds in BRGSF-HIS mice
- Use of genO-hFcγR model to investigate the Fc-mediate effector functions of therapeutic antibodies
Come visit us at Booth #22!
If you cannot meet us at the conference, reach out to our team by filling out the contact form below
NextGen Biomed 2025, London, UK, March 12-14, 2025
Get in touch
Let us know how we can help
Other news & events
Scientific excellence
From model design to experimental results
Featured in 600+ scientific articles
Collaborative approach
Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions
Robust validation data on catalog models
Generated with biopharma partners and in-house
Innovative technologies
and guaranteed freedom to operate
Easy access to models
Models with certified health status from professional breeders in US and Europe